Schmitt HP, Esmer W, Heimes C: Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia. Ann Neurol 16:642, 1984.
Schneider LS, Tarlot PN, Dagerman KS, et al: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med 355:1525, 2006.
Schoenfeld M, Myers RH, Cupples LA, et al: Increased rate of suicide among patients with Huntington’s disease. J Neurol Neurosurg Psychiatry 47:1283, 1984.
Schoonenboom NSM, Reesink FE, Verwey NA, et al: Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78:47, 2012.
Schuepbach WMM, Rau J, Knudsen K, et al: Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 368:610, 2013.
Scribanu N, Kennedy C: Familial syndrome with dystonia, neural deafness and possible intellectual impairment: Clinical course and pathologic features. In: Eldridge R, Fahn S (eds): Advances in Neurology. Vol 14: Dystonia. New York, Raven Press, 1976, pp 235–245.
Segawa M, Hosaka A, Miyagawa F, et al: Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 14:215, 1976.
Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a gene bearing missense imitations in early-onset familial Alzheimer’s disease. Nature 375:754, 1995.
Shults CW, Oakes D, Kieburtz K, et al: Effects of coenzyme Q10 in early Parkinson disease. Evidence of slowing of functional decline. Arch Neurol 59:1541, 2002.
Sidransky E, Nalls MA, Aasly JO, et al: Multicenter analysis if glucocerbroside mutations in Parkinson’s disease. N Engl J Med 361:1651, 2009.
Silverman JM, Raiford K, Edland S, et al: The consortium to establish a registry for Alzheimer’s disease (CERAD). Neurology 44:1253, 1994.
Singleton AB, Farrar M, Johnson J, et al: alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302:841, 2003.
Skre H: Hereditary spastic paraplegia in western Norway. Clin Genet 6:165, 1974.
Snowden DA, Kemper SJ, Mortimer JA, et al: Linguistic ability in late life: Findings from the Nun study. JAMA 275:528, 1996.
Snowden JS, Neary D, Mann DMA: Progressive language disorder due to lobar atrophy. Ann Neurol 31:174, 1992.
Snyder SH, D’Amato RJ: MPTP: A neurotoxin relevant to the pathophysiology of Parkinson’s disease. Neurology 36:250, 1986.
Spencer DD, Robbins RJ, Naftolin F, et al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson’s disease. N Engl J Med 327:1541, 1992.